December 24, 2022
dvm360 Staff
dvm360, dvm360 December 2022, Volume 53, Issue 12
Pages: 26
We person compiled a countdown of our apical 20 articles successful 2022, present is fig 8
8. FDA approves long-acting transdermal buprenorphine for cats
By dvm360® staff
Advertisement
The FDA announced earlier this twelvemonth it approved buprenorphine transdermal solution (Zorbium; Elanco Animal Health) for controlling postoperative symptom successful cats. This signaled Elanco’s enlargement into symptom absorption offerings.
Click here to work the afloat article.
Download Issue: dvm360 December 2022
English (US)